Bank of New York Mellon’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.21M | Buy |
212,179
+90,727
| +75% | +$515K | ﹤0.01% | 3017 |
|
2025
Q1 | $578K | Hold |
121,452
| – | – | ﹤0.01% | 3362 |
|
2024
Q4 | $676K | Hold |
121,452
| – | – | ﹤0.01% | 3347 |
|
2024
Q3 | $768K | Sell |
121,452
-1
| -0% | -$6 | ﹤0.01% | 3274 |
|
2024
Q2 | $515K | Buy |
121,453
+2,434
| +2% | +$10.3K | ﹤0.01% | 3565 |
|
2024
Q1 | $863K | Buy |
119,019
+105,699
| +794% | +$766K | ﹤0.01% | 3224 |
|
2023
Q4 | $66.7K | Buy |
13,320
+386
| +3% | +$1.93K | ﹤0.01% | 4133 |
|
2023
Q3 | $54.5K | Hold |
12,934
| – | – | ﹤0.01% | 4147 |
|
2023
Q2 | $52.1K | Buy |
+12,934
| New | +$52.1K | ﹤0.01% | 4163 |
|
2022
Q3 | – | Sell |
-1,763
| Closed | -$9K | – | 4546 |
|
2022
Q2 | $9K | Hold |
1,763
| – | – | ﹤0.01% | 4552 |
|
2022
Q1 | $14K | Hold |
1,763
| – | – | ﹤0.01% | 4627 |
|
2021
Q4 | $15K | Sell |
1,763
-2,153
| -55% | -$18.3K | ﹤0.01% | 4598 |
|
2021
Q3 | $110K | Hold |
3,916
| – | – | ﹤0.01% | 4309 |
|
2021
Q2 | $153K | Sell |
3,916
-7,053
| -64% | -$276K | ﹤0.01% | 4143 |
|
2021
Q1 | $516K | Sell |
10,969
-260
| -2% | -$12.2K | ﹤0.01% | 3666 |
|
2020
Q4 | $441K | Buy |
11,229
+798
| +8% | +$31.3K | ﹤0.01% | 3676 |
|
2020
Q3 | $266K | Sell |
10,431
-326
| -3% | -$8.31K | ﹤0.01% | 3760 |
|
2020
Q2 | $784K | Buy |
10,757
+798
| +8% | +$58.2K | ﹤0.01% | 3241 |
|
2020
Q1 | $524K | Buy |
9,959
+1,968
| +25% | +$104K | ﹤0.01% | 3337 |
|
2019
Q4 | $652K | Buy |
7,991
+2,114
| +36% | +$172K | ﹤0.01% | 3451 |
|
2019
Q3 | $333K | Sell |
5,877
-472
| -7% | -$26.7K | ﹤0.01% | 3737 |
|
2019
Q2 | $759K | Buy |
6,349
+760
| +14% | +$90.9K | ﹤0.01% | 3375 |
|
2019
Q1 | $1.03M | Sell |
5,589
-1
| -0% | -$184 | ﹤0.01% | 3156 |
|
2018
Q4 | $998K | Sell |
5,590
-122
| -2% | -$21.8K | ﹤0.01% | 3101 |
|
2018
Q3 | $1.83M | Buy |
5,712
+51
| +0.9% | +$16.3K | ﹤0.01% | 2888 |
|
2018
Q2 | $2.27M | Sell |
5,661
-35
| -0.6% | -$14K | ﹤0.01% | 2786 |
|
2018
Q1 | $2.04M | Sell |
5,696
-2,123
| -27% | -$761K | ﹤0.01% | 2787 |
|
2017
Q4 | $3.1M | Buy |
7,819
+3,699
| +90% | +$1.47M | ﹤0.01% | 2587 |
|
2017
Q3 | $1.76M | Buy |
4,120
+120
| +3% | +$51.1K | ﹤0.01% | 2912 |
|
2017
Q2 | $640K | Buy |
4,000
+2,323
| +139% | +$372K | ﹤0.01% | 3485 |
|
2017
Q1 | $210K | Buy |
1,677
+934
| +126% | +$117K | ﹤0.01% | 3862 |
|
2016
Q4 | $90K | Buy |
+743
| New | +$90K | ﹤0.01% | 4039 |
|
2016
Q2 | – | Sell |
-823
| Closed | -$53K | – | 4313 |
|
2016
Q1 | $53K | Buy |
823
+77
| +10% | +$4.96K | ﹤0.01% | 4069 |
|
2015
Q4 | $63K | Buy |
746
+11
| +1% | +$929 | ﹤0.01% | 4114 |
|
2015
Q3 | $74K | Sell |
735
-312
| -30% | -$31.4K | ﹤0.01% | 4133 |
|
2015
Q2 | $132K | Buy |
+1,047
| New | +$132K | ﹤0.01% | 3983 |
|